Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Chiocca

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Clinical Neurosurgery|January 1, 1995
Brain tumor gene therapy in mice with a novel "suicide" gene: the cyclophosphamide-activating CYP2B1 geneE A Chiocca
Cancer Investigation|May 15, 2003
Genetically engineered herpes simplex viral vectors in the treatment of brain tumors: a reviewManish Aghi, E A Chiocca
Ophthalmic Research|March 4, 1998
Marker gene transfer and oncolysis of human Y79 retinoblastoma cells mediated by herpes simplex virus mutantsM Nicolò, E A Chiocca
Neuroreport|April 14, 1994
Nerve growth factor protects against herpes simplex virus type 1 neurotoxicity in the rat striatumP Pakzaban, E A Chiocca
Cancer Research|July 17, 2001
Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vectorT Ichikawa, E A Chiocca
Expert Opinion on Investigational Drugs|November 4, 2000
Oncolytic viruses as novel anticancer agents: turning one scourge against anotherE R Smith, E A Chiocca
Critical Reviews in Oncogenesis|February 2, 2000
A review of gene therapy for the treatment of central nervous system tumorsN H Qureshi, E A Chiocca
Surgical Oncology Clinics of North America|June 13, 1998
Gene therapy for tumors of the central nervous systemR Y Chung, E A Chiocca
Cytokine & Growth Factor Reviews|March 16, 2010
Directing systemic oncolytic viral delivery to tumors via carrier cellsHiroshi Nakashima, Balveen Kaur, E A Chiocca
Nature Biotechnology|May 21, 1998
An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapyM Chase, R Y Chung, E A Chiocca
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Clinical Neurosurgery|January 1, 1995
Brain tumor gene therapy in mice with a novel "suicide" gene: the cyclophosphamide-activating CYP2B1 geneE A Chiocca
Cancer Investigation|May 15, 2003
Genetically engineered herpes simplex viral vectors in the treatment of brain tumors: a reviewManish Aghi, E A Chiocca
Ophthalmic Research|March 4, 1998
Marker gene transfer and oncolysis of human Y79 retinoblastoma cells mediated by herpes simplex virus mutantsM Nicolò, E A Chiocca
Neuroreport|April 14, 1994
Nerve growth factor protects against herpes simplex virus type 1 neurotoxicity in the rat striatumP Pakzaban, E A Chiocca
Cancer Research|July 17, 2001
Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vectorT Ichikawa, E A Chiocca
Expert Opinion on Investigational Drugs|November 4, 2000
Oncolytic viruses as novel anticancer agents: turning one scourge against anotherE R Smith, E A Chiocca
Critical Reviews in Oncogenesis|February 2, 2000
A review of gene therapy for the treatment of central nervous system tumorsN H Qureshi, E A Chiocca
Surgical Oncology Clinics of North America|June 13, 1998
Gene therapy for tumors of the central nervous systemR Y Chung, E A Chiocca
Cytokine & Growth Factor Reviews|March 16, 2010
Directing systemic oncolytic viral delivery to tumors via carrier cellsHiroshi Nakashima, Balveen Kaur, E A Chiocca
Nature Biotechnology|May 21, 1998
An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapyM Chase, R Y Chung, E A Chiocca
Pageof 11